Overview

The Effect of Rifapentine on Raltegravir

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to study the effect of rifapentine on plasma concentrations of raltegravir.
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborators:
Centers for Disease Control and Prevention
Merck Sharp & Dohme Corp.
VA Office of Research and Development
Treatments:
Raltegravir Potassium
Rifampin
Rifapentine